Quarterly report pursuant to Section 13 or 15(d)

Significant Transactions (Details Textual)

v3.22.1
Significant Transactions (Details Textual) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Oct. 10, 2021
Oct. 01, 2021
Apr. 01, 2021
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Dec. 31, 2021
Business Acquisition [Line Items]              
Exchangeable shares     1,000,000        
Revenues       $ 6,950,841 $ 4,014,024    
Common stock issued in business combinations       $ 940,000      
Common stock, shares issued       34,175,088   34,175,088 34,175,088
Preferred stock, par value       $ 0.0001   $ 0.0001 $ 0.0001
Preferred stock, liquidation preference per share       $ 1      
Impairment of goodwill       $ 0      
Acquisition of net income       $ 6,574,000      
Ample Organics [Member]              
Business Acquisition [Line Items]              
Exchangeable shares       2,434      
Aggregate value of exchangeable shares       $ 18,620      
Exchangeable shares issued       306,852      
Viridian Sciences [Member]              
Business Acquisition [Line Items]              
Reduction of contingent consideration           $ 6,000,000  
Stock Consideration in Cash     $ 1,000,000        
Cannabis [Member]              
Business Acquisition [Line Items]              
Cash   $ 5,000,000          
Common stock issued in business combinations $ 12,000,000            
Aggregate stock price   8,000,000          
365 Cannabis [Member]              
Business Acquisition [Line Items]              
Cash   $ 527,000          
Common stock, shares issued   3,600,000          
Value of shares issued for exchangeable shares   $ 11,060,000          
Reduction of purchase price       $ 1,500,000      
Receivables booked in other current assets       400,000      
Reduction of working capital             $ 160,000
Shares held in escrow, value       $ 940,000      
Shares held in escrow       279,762